C. Goeldner

发表

Nociceptin Receptor Impairs Recognition Memory via Interaction with NMDA Receptor-Dependent Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Signaling in the Hippocampus

H. Meziane, B. Kieffer, A. Ouagazzal, 2008, The Journal of Neuroscience.

Activation of nociceptin opioid peptide (NOP) receptor impairs contextual fear learning in mice through glutamatergic mechanisms

B. Kieffer, A. Ouagazzal, J. Wichmann, 2009, Neurobiology of Learning and Memory.

Further characterization of the prototypical nociceptin/orphanin FQ peptide receptor agonist Ro 64-6198 in rodent models of conflict anxiety and despair

W. Spooren, E. Prinssen, J. Wichmann, 2012, Psychopharmacology.

A randomized, double-blind, placebo-controlled phase II trial to explore the effects of a GABAA-α5 NAM (basmisanil) on intellectual disability associated with Down syndrome

J. Hipp, M. Rafii, P. Fontoura, 2022, Journal of neurodevelopmental disorders.

Impaired Emotional-Like Behavior and Serotonergic Function During Protracted Abstinence from Chronic Morphine

B. Kieffer, D. Clesse, P. Lutz, 2011, Biological Psychiatry.

Adaptive behavior in adolescents and adults with Down syndrome: Results from a 6‐month longitudinal study

Sarah J. Hart, L. Squassante, G. Spiridigliozzi, 2018, American journal of medical genetics. Part A.

Assessment of Cognitive Scales to Examine Memory, Executive Function and Language in Individuals with Down Syndrome: Implications of a 6-month Observational Study

L. Squassante, G. Spiridigliozzi, O. Khwaja, 2015, Front. Behav. Neurosci..

Endogenous nociceptin/orphanin‐fq in the dorsal hippocampus facilitates despair‐related behavior

B. Kieffer, A. Ouagazzal, C. Goeldner, 2010, Hippocampus.

Sequential and opposing alterations of 5-HT1A receptor function during withdrawal from chronic morphine

B. Kieffer, P. Lutz, A. Pradhan, 2011, European Neuropsychopharmacology.

Further characterization of the prototypical nociceptin/orphanin FQ peptide receptor agonist Ro 64-6198 in rodent models of conflict anxiety and despair

W. Spooren, E. Prinssen, J. Wichmann, 2012, Psychopharmacology.

PEGylation enhances the therapeutic potential for insulin-like growth factor I in central nervous system disorders.

F. Metzger, W. Spooren, L. Ozmen, 2011, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Cognitive impairment in major depression and the mGlu2 receptor as a therapeutic target

D. Umbricht, F. Knoflach, S. Gatti, 2013, Neuropharmacology.

Endogenous nociceptin/orphanin‐fq in the dorsal hippocampus facilitates despair‐related behavior

B. Kieffer, A. Ouagazzal, C. Goeldner, 2010, Hippocampus.

Activation of nociceptin opioid peptide (NOP) receptor impairs contextual fear learning in mice through glutamatergic mechanisms

B. Kieffer, A. Ouagazzal, J. Wichmann, 2009, Neurobiology of Learning and Memory.

A randomized, double-blind, placebo-controlled phase II trial to explore the effects of a GABAA-α5 NAM (basmisanil) on intellectual disability associated with Down syndrome

J. Hipp, M. Rafii, P. Fontoura, 2022, Journal of Neurodevelopmental Disorders.